The enhanced antitumour response of pimozide combined with the IDO inhibitor L-MT in melanoma

Melanoma is one of the most fatal and therapy-resistant types of cancer; therefore, identifying novel therapeutic candidates to improve patient survival is an ongoing effort. Previous studies have revealed that pimozide is not sufficient to treat melanoma; therefore, enhancing the treatment is neces...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Huijie, Ren, Wenjing, Feng, Yuchen, Wei, Tian, Guo, Mengmeng, Guo, Jing, Zhao, Jingjing, Song, Xiangfeng, Wang, Mingyong, Zhao, Tiesuo, Wang, Hui, Feng, Zhiwei, Tian, Zhongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065445/
https://www.ncbi.nlm.nih.gov/pubmed/30015838
http://dx.doi.org/10.3892/ijo.2018.4473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065445/
https://www.ncbi.nlm.nih.gov/pubmed/30015838
http://dx.doi.org/10.3892/ijo.2018.4473

Ejemplares similares